Frontiers in Genetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2022-05-27 ms1000001205788873

偏重的研究方向：生物信息
经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔

54 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2023-02-26 少年宁来自浙江省

偏重的研究方向：肿瘤;纯生信;基因
经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！

57 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2024-05-08 ms3000000420360328 来自浙江省

This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final.

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2024-01-04 ms3000000029380120 来自江苏省

审稿速度:2.0
经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中.......

160 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2023-07-01 287119938 来自贵州省

审稿速度:6.0
经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。

66 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2023-06-16 ms9000001727788658 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：点突变
经验分享：麻烦问下，从接收到正式发表，需要多长时间呀

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2022-09-01 ms8000000941284145

偏重的研究方向：肿瘤;基因;生信
经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。

91 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2022-11-12 ms9000000913432311

偏重的研究方向：纯生信;生信;生物信息
经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2021-05-19 哈哈小猪

第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？

92 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2143081, encodeId=03f3214308163, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：点突变 经验分享：麻烦问下，从接收到正式发表，需要多长时间呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fceb6442587, createdName=ms9000001727788658, createdTime=Fri Jun 16 09:24:12 CST 2023, time=2023-06-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1242528, encodeId=2c241242528ae, content=偏重的研究方向：肿瘤;基因;生信 经验分享：合伙搞了篇生信，投稿时需要原始数据，今天上传了，希望编辑和审稿人给过吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c696163486, createdName=ms8000000941284145, createdTime=Thu Sep 01 18:13:31 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100097, encodeId=5140210009e8e, content=偏重的研究方向：纯生信;生信;生物信息 经验分享：请问一下纯生信的只给原始数据不上传代码可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e795651310, createdName=ms9000000913432311, createdTime=Sat Nov 12 16:13:48 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966740, encodeId=3f85966e40d3, content=第一次见到这种杂志哦，已经accepted for publication了，而且版面费都交了，结果突然来了一封信说拒稿退钱，这是什么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/19/fe015ad718825715f9776074575b45f8.jpg, createdBy=85a02541803, createdName=哈哈小猪, createdTime=Wed May 19 07:41:33 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119119, encodeId=27f4211911946, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4个审稿人，纯生信文章，2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220704/1acf1fcc54b540239da4b101eb02ebc4/379539e2ee554698a231b4f45583be89.jpg, createdBy=62942283774, createdName=董柏, createdTime=Sun Mar 12 20:33:55 CST 2023, time=2023-03-12, status=1, ipAttribution=浙江省)]

2023-03-12 董柏来自浙江省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：4个审稿人，纯生信文章，2个半月

56 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务